alexa
Reach Us +1(850)754-6199
New Defence Mechanism Against Viruses And Cancer | 4743
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

New defence mechanism against viruses and cancer

3rd World Congress on Biotechnology

Arjun Muthukrishnan, V. Nagendra Babu and V.S. Tejaswini

Posters: Agrotechnol

DOI: 10.4172/2155-952X.S1.020

Abstract
Introduction: Many drugs and therapies have been developed for treating viral infections, HIV/AIDS, cancer but with little success or adverse and toxic effects on the organisms. Scientists have found a mechanism which might help us fight with these, dreadful disease. Interluekin 33: IL-33 is a cytokine belonging to the IL-1 superfamily. IL-33 induces helper T cells, mast cells, eosinophils and basophils to produce type 2 cytokines. This cytokine was previously named NF-HEV ?nuclear factor (NF) in high endothelial venules? (HEVs) since it was originally identified in these specialized cells. IL-33 mediates its biological effects by interacting with the receptors ST2 (aka IL1RL1) and IL-1 Receptor Accessory Protein (IL1RAP), activating intracellular molecules in the NF-κB and MAP kinase signaling pathways that drive production of type 2 cytokines (e.g. IL-5 and IL-13) from polarized Th2 cells. The induction of type 2 cytokines by IL-33 in vivo is believed to induce the severe pathological changes observed in mucosal organs following administration of IL-33. Experiment: Scientist have exploited the mechanism of vaccination and found that when a foreign or viral particle enters our body which are regarded as PAMP?s, these cells alert the dendritic cells and there by alert T-cells but the new mechanism found, relates the activity of dendritic cells with the injured cells which give out alarmins(factor) responsible for stimulating T-cells i.e., Interluekin 33(IL-33).It forms scaffold for T-cells and improves their activity and thus T-cells destroy the foreign or cancerous cells. It was found when a mouse was knocked out of the gene responsible for IL33 it could not sustain the viral attacks Conversely, IL-33 could be used to artificially increase the T killer cell army, which was generated in response to vaccination. Result: The ?foreign look? of viruses (PAMPs) activates the ?dendritic cell? policemen to engage T killer cells. T killer cells, however, remain lousy fighters unless alerted by a cell death in their neighborhood. These new findings could provide a key to effective vaccination against infectious diseases and cancer.
Biography
Top